From University of Minnesota Masonic Children's Hospital, Minneapolis, MN.
the Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA.
J Pediatr Gastroenterol Nutr. 2023 Dec 1;77(6):713-719. doi: 10.1097/MPG.0000000000003957. Epub 2023 Sep 27.
Greater hepatitis-related symptomology is associated with lower health-related quality-of-life (HRQoL) among untreated youth with chronic hepatitis B (CHB). How HRQoL changes over time in this population is unknown.
Children from 7 hepatology centers in North America positive for hepatitis B surface antigen, not taking anti-viral therapy, were enrolled in the Hepatitis B Research Network. A validated self-report HRQoL measure, the Child Health Questionnaire Child Report (CHQ-CF87), was completed annually by participants 10-17 years, with demographic variables, liver disease symptoms, and laboratory tests. Linear mixed-effects models were used to evaluate the 10 CHQ-CF87 subscale scores over 5 years among participants who completed the CHQ-CF87 at least twice.
Participants (N = 174) completed the CHQ-CF87 a median of 4 times. Median age was 12 years (interquartile range: 10-14) at baseline; 60% were female, 79% Asian, and 47% adopted. The CHQ-CF87 subscale scores were high at baseline (median range: 75.4-100) and did not differ by time point, except for the Family Activities subscale (mean [95% CI]: 82.3 [79.8-84.8] at baseline; 90.8 [86.1-94.6] week 240). Most subscale scores lacked sufficient individual-level variability in change over time to evaluate predictors. Being White versus Asian predicted a more favorable change in Behavior (6.5 [95% CI: 2.0-11.0]). Older age predicted less favorable change in Mental Health (-0.8 [95% CI: -1.36 to -0.23] per year). Changes in liver enzymes and hepatitis B antigens, DNA, or symptom count were not related to changes in these subscale scores.
HRQoL was generally good and consistent across 5 years in youth with CHB.
未经治疗的慢性乙型肝炎(CHB)青少年患者的肝炎相关症状越严重,其健康相关生活质量(HRQoL)越低。目前尚不清楚该人群的 HRQoL 随时间的变化情况。
北美 7 家肝病中心的乙型肝炎表面抗原阳性、未接受抗病毒治疗的儿童入组乙型肝炎研究网络。参与者(年龄 10-17 岁)每年使用经过验证的自评 HRQoL 量表儿童健康问卷儿童报告(CHQ-CF87)进行自我报告,同时报告人口统计学变量、肝脏疾病症状和实验室检查结果。采用线性混合效应模型评估至少完成 2 次 CHQ-CF87 量表评估的参与者在 5 年内的 10 个 CHQ-CF87 子量表评分变化情况。
共 174 名参与者完成了 CHQ-CF87 量表的评估,中位数完成 4 次。基线时的中位年龄为 12 岁(四分位间距:10-14);60%为女性,79%为亚裔,47%为领养。CHQ-CF87 子量表评分在基线时较高(中位数范围:75.4-100),且除家庭活动子量表(平均值[95%CI]:基线时为 82.3[79.8-84.8];240 周时为 90.8[86.1-94.6])外,各时间点的评分均无差异。大多数子量表评分在随时间变化的个体水平上缺乏足够的可变性,无法评估预测指标。与亚裔相比,白人的行为变化更有利(6.5[95%CI:2.0-11.0])。年龄较大与心理健康的变化呈负相关(每年减少 0.8[95%CI:-1.36 至-0.23])。肝酶和乙型肝炎抗原、DNA 或症状计数的变化与这些子量表评分的变化无关。
在 CHB 青少年中,HRQoL 在 5 年内总体良好且保持一致。